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STUDIES ON THE ORIGIN AND SIGNIFICANCE OF BLOOD AMMONIA.
1. Effect of Various Anticoagulants on the Blood Ammonia Determination**
Resurgence of interest in ammonia metabolism in liver disease has re-
sulted in extensive use of the blood ammonia determination as a clinical
and investigative tool. Almost all methods for the determination of ammonia
in blood are based on the liberation of ammonia by alkalinization, diffusion
of the ammonia into an acid medium, followed by titrimetric or colorimetric
quantitation. Although widely used, these measurements have been accepted
with reservations for several reasons. First, a wide variation in the normal
range of blood ammonia concentration has been reported from various
laboratories."5 These may be attributed to technical differences in degree
of alkalinization, "'8 duration of diffusion,8'e'9 interval between the shed-
ding of blood and its analysis,""' temperature1' l" and other factors.
Secondly, there has been controversy over whether free ammonia actually
exists in the circulating blood of normal individuals. Conway observed a
sharp rise in the blood ammonia concentration immediately after shedding
and concluded that the circulating blood of normal individuals does not
contain free ammonia.' Some investigators have confirmed this observa-
tione9'1 but others, using the same or different methods, have been unable to
do so.' 7'-
` 'l Although it appears that free ammonia does exist in blood
in low concentrations,19'f one must assume that the blood ammonia levels,
as measured by some, if not all, of these different techniques, are arti-
factually high or low.
The recent observation that different commercial brands and concen-
trations of heparin contain variable amounts of ammonia which may arti-
factually affect the blood ammonia level,' has led to investigations of the
effect of other anticoagulants. Use of anticoagulants such as heparin, potas-
sium oxalate and sodium fluoride, which are themselves ammonia-free,
may affect the blood ammonia determination to different degrees.-' These
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observations suggest possible explanations for some of the variations in
blood ammonia levels reported in the literature. Furthermore, investigation
of the effect of various anticoagulants on the blood ammonia concentration
may provide a clue to the source and significance of the ammonia found
in blood.
The present study was undertaken to evaluate the effect of various anti-
coagulants on the blood ammonia determination, and to investigate the
nature of these phenomena.
METHODS AND MATERIALS
All blood ammonia determinations were performed in duplicate or triplicate using
the Seligson-Hirahara technique.4 Sodium heparin solution (10 mg. per ml., Organon,
Inc.), which contained negligible amounts of ammonia, was used as the reference
anticoagulant with which other anticoagulants were compared.' The other anti-
coagulants, which included sodium oxalate, potassium oxalate, sodium citrate, sodium
ethylenediaminetetraacetate (EDTA) and sodium fluoride, were rendered ammonia-
free by alkalinization and recrystallization after readjustment of pH to 7.4. Blood was
drawn without stasis into dry sterile syringes, immediately transferred to test tubes
containing measured amounts of the appropriate anticoagulants and mixed by gentle
inversion. After 10 minutes at room temperature the test tubes were again mixed and
the ammonia concentration measured.
The ammonia concentration of heparinized blood was compared in turn with blood
anticoagulated with each of the other anticoagulants, and with non-anticoagulated
blood. The order of analysis was randomized within each series of comparisons which
consisted of at least 25 different blood specimens. In each series the blood was obtained
predominantly from cirrhotic patients, but also from patients with a variety of other
disorders, and from normal subjects.
The effect of temperature was studied by simultaneously incubating aliquots of blood
which had been anticoagulated with heparin, potassium oxalate, and sodium fluoride in
constant temperature water baths at 20 C., room temperature (mean 220 C.), and 38° C.
The order of analysis was rotated' in regard to the anticoagulant and the temperature
of incubation.
Studies to investigate the effect of the interval between the withdrawal of blood and
its analysis in respect to the effect of each anticoagulant on the blood ammonia concen-
tration were carried out in the following manner. Venous blood was rapidly drawn
into calibrated two ml. syringes containing measured amounts of anticoagulant solution,
and immediately ejected into the alkali-containing diffusion bottles through a three-way
stopcock (Fig. 1). A fresh syringe was used for each of four samples. The average time
interval from the appearance of blood in the syringe to its delivery into the diffusion
bottle was eight seconds and ranged from 5 to 12 seconds. Although the volume of
blood transferred was approximately two ml. in all instances, the exact volume was
determined by weight, and the blood ammonia concentration was corrected for varia-
tions in volume. Immediately after the fourth sample, blood was withdrawn and anti-
coagulated in the usual manner and the blood ammonia concentration determined after
172
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FIG. 1. Method employed to introduce blood into reaction vessel within a few seconds
of withdrawal. As soon as the syringe had been filled to the 2 ml. mark the stopcock
was turned and the blood ejected into the alkali-containing reaction bottle.Effect of anticoagulants on blood ammonia I CONN
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10 and 20 minute incubation periods at room temperature. Each anticoagulant was
studied in this manner on at least ten occasions. A heparinized blood sample served
as a reference value when other anticoagulants were being studied.
The effect of the various anticoagulants on the pH of blood was determined
immediately after withdrawal and at intervals up to 20 minutes with the Metrohm
pH meter.*
RESULTS
The concentrations of the various anticoagulants and their effects on
the blood ammonia determination are summarized in Table 1.
EFFECT OF TIME INTERVAL AFTER SHEDDING
ON THE BLOOD AMMONIA CONCENTRATION
NH3, N ____w
lOOml,.r
200CoNo 5 102
TIME INTERVAL AFTER SHEDDING in minutes
FIG. 2. Ammonia levels of blood anticoagulated with various anticoagulants are
plotted at 8 second and 10 and 20 minute intervals after withdrawal. Each line
represents the mean of 10 patients studied with a different anticoagulant.
Sodium Ethylenediaminetetraacetate (EDTA). The ammonia concen-
tration of blood specimens which were anticoagulated with EDTA or
heparin were virtually identical. In a separate series of analyses the
ammonia levels of blood anticoagulated with a commercial prepara-
tion of EDTA (Sequestrene Vacutainers®) were slightly, but signifi-
cantly, higher than with heparinized blood (Table 2). This mean
increment of 5.6 ,ug. per 100 ml. was due to contamination of the
EDTA with small amounts of ammonia which added approximately 6
,ug. per 100 ml. to each blood sample. Although this small increment was
of no practical importance, it demonstrated the accurate recovery by this
technique of small amounts of ammonia added to blood. There was no
* Dr. Robert Nims kindly performed the pH measurements.
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difference in the blood ammonia level when either liquid or powdered
EDTA was used, or when the pH of the EDTA was neutral or alkaline
(pH 10) (Table 2). The ammonia concentration of blood which was
anticoagulated with EDTA remained constant from the time of with-
drawal for at least twenty minutes after shedding (FIG. 2).
Potassium oxalate. Potassium oxalate anticoagulation resulted in a highly
significant increase in blood ammonia values which averaged 15 jug. per
TABLE2. THEEFFECT OFEDTAON THEBLOODAMMONIADETERMINATION
Difference
blood
ammonia
Mean (Mean ±
blood standard
ammonia error)
(Ag. NH. N per 100 ml.)
Statistical
significance
(paired"t"test)
Heparin
EDTA (ammonia-free)
Heparin
EDTA (Sequestrene*)
EDTA (liquid)
EDTA (powder)
EDTA(pH 7.0)
EDTA (pH 10.0)
173
174 25
136
142 25
15
10
186
190
221
222
0.9 + 2.34 Not significant
5.6 + 2.36 p <0.05
3.7 + 2.04 Not significant
1.3 + 2.70 Not significant
* Sequestrene (Upjohn) contributed 6 ,ug. NHs N per 100 ml.
100 ml. higher than with heparin anticoagulation. It made no difference
whether the potassium oxalate was used in liquid or powdered form or
whether sodium or potassium oxalate was used (Table 3). Varying the
concentration of potassium oxalate from 1.25 to 25.0 mg. per ml. of blood
did not significantly alter the oxalate-induced increment in blood ammonia
levels (Table 3). Prior heparinization of the blood did not prevent the
increment (Table 3). Immediately after shedding, the ammonia levels of
oxalated blood were identical with those of heparinized blood. The ammonia
concentration of oxalated blood, however, rose as a function of the interval
between the time of shedding and its analysis (Fig. 2). These increments
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were 14 and 23 Mg. per 100 ml. at 10 and 20 minutes after withdrawal
respectively.
The oxalate-induced rise in blood ammonia concentration was minimized
in the cold, and accelerated by increasing the temperature. The ammonia
concentration of heparinized blood, however, was not temperature-depend-
ent (Fig. 3).
Sodium fluoride. Anticoagulation of blood with sodium fluoride resulted
in mean blood ammonia values which were 27.8 ,ug. per 100 ml. higher than
EFFECT OF TEMPERATURE ON THE AMMONIA
CONCENTRATION OF BLOOD ANTICOAGULATED
400- WITH VARIOUS ANTICOAGULANTS OI MORIDE
350-
300-
1LOOD POTASSIUN OXALATE AMMONIA
in Ag 250-
NH3 N
per
IOOmi. 200-
.______________________________________________________
_ *HEPARIN
15C-
100-
i5 bO 15 20 2T i5 3b 5 T 4b
TEMPERATURE IN DEGREES CENTIGRADE
FIG. 3. The curves represent the mean blood ammonia values of ten patients
studied simultaneously at three temperatures with three anticoagulants.
blood anticoagulated with heparin. There was no significant difference in
blood ammonia levels between sodium fluoride employed as a solution or
as a powder (Table 4). Increasing the concentration of sodium fluoride
from 2.5 to 10 mg. per ml. blood did not alter the magnitude of the increment
in blood ammonia concentration (Table 4). Prior heparinization of the
blood did not prevent the rise in blood ammonia levels induced by sodium
fluoride (Table 4).
Immediately after shedding, the ammonia concentration of fluoridated
blood was almost identical with heparinized blood. The ammonia concen-
tration of blood anticoagulated with sodium fluoride rose progressively
thereafter as a function of the time interval between its withdrawal and
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its analysis (Fig. 2). This rise could be prevented by incubation at 20 C.
and accelerated at 380 C. (Fig. 3). Fluoride-induced increments in ammonia
concentration at various temperatures were much greater than those ob-
served with potassium oxalate.
No anticoagulation. A small but statistically significant increase in the
ammonia concentration of unanticoagulated blood was observed as compared
to heparinized blood (Table 1).
No significant change in the pH of blood occurred during the twenty
minutes after shedding with any of the anticoagulants employed.
TABLE 5. EFFECT OF TIME INTERVAL AFTER SHEDDING ON THE
BLOOD AMMONIA CONCENTRATION
Interval after shedding
Anticoagulant No. <10 Seconds 10 Minutes 20 Minutes
(Blood ammonia in ,ug. NHs N per 100 ml.)
Heparin 20 164 166 164
EDTA 11 156 154 158
Potassium oxalate 10 127 141 150
Sodium fluoride 10 139 156 188
I)ISCUSSION
The only previous investigations on the effects of different anticoagulants
on the blood ammonia determination were reported by De Groote and
Vandenbroucke.' These authors using the Seligson-Seligson ammonia
method' found no significant difference in the ammonia concentration of
blood anticoagulated with heparin or EDTA. They observed small incre-
ments with sodium citrate and potassium oxalate, which were exaggerated
by prolonged incubation.
The present studies confirm and extend these observations. Heparin
and EDTA appear to have a similar effect. Identical blood ammonia levels
are found with these anticoagulants, and they remain constant for at least
twenty minutes after withdrawal. Furthermore, incubation over a wide tem-
perature range causes no appreciable change in the blood ammonia con-
centration.
Although heparinized and oxalated blood have the same ammonia con-
centration at the time of shedding, potassium oxalate induces a moderate
rise in the blood ammonia concentration which increases as the interval
179YALE JOURNAL OF BIOLOGY AND MEDICINE
between its withdrawal and analysis lengthens. This can be inhibited almost
completely by lowering the temperature to 2° C., and accelerated by in-
creasing the temperature to 380 C.
Despite the similar blood ammonia levels of heparinized and fluoridated
blood at the time of withdrawal, sodium fluoride induces a large increase in
the blood ammonia concentration. This increment which rises as a function
of the time after shedding, can be minimized in the cold or enormously
enhanced by increasing the temperature of incubation to 380 C. The
slightly higher levels of ammonia observed in blood anticoagulated with
TABLE 6. EFFECTS OF TEMPERATURE AND ANTICOAGULANTS ON THE
BLOOD AMMONIA CONCENTRATION
Concentration T e m p e r a t u r e
Anticoagulant mg. per ml. blood No. 20 C. 220 C. 380 C.
Heparin (0.1 mg.) 10 176 183 184
Potassium oxalate (2.5 mg.) 10 190 217 267
Sodium fluoride (2.5 mg.) 10 187 265 399
oxalate or fluoride at 20 C. probably represented increments which took
place during temperature equilibration.
The ammonia concentration of non-anticoagulated blood is slightly, but
significantly, higher than heparinized blood. Blood anticoagulated with
sodium citrate also gave ammonia values slightly higher than heparinized
blood.
The magnitude of the anticoagulant-induced increments were inde-
pendent of the basal blood ammonia level, and of the presence or absence of
cirrhosis.
The explanation for these phenomena is not apparent. These observations,
however, do permit the formulation of several working hypotheses. The
first, which may be considered a "unified" hypothesis, suggests that there
occurs a gradual increase in ammonia concentration of blood after with-
drawal from the body. This small increment which occurs even in non-
anticoagulated blood may be considered a natural phenomenon. It may be
prevented, however, by anticoagulation with heparin or EDTA, but may
be unaffected by sodium citrate. Potassium oxalate and sodium fluoride
potentiate the ammonia-liberating process to different degrees.
The second, a non-unified assumption, presupposes that the "natural"
rise in ammonia levels of non-anticoagulated blood is a function of the
180
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coagulation process, which may be prevented by any anticoagulants. This
implies that sodium citrate, potassium oxalate and sodium fluoride exert
their effects by different mechanisms, or conceivably, by influencing the
same mechanism to different degrees.
By what mechanisms might these anticoagulant-induced effects be
mediated? It is unlikely that they are related to the anticoagulant activity,
per se, of these substances. Although the anticoagulant mechanisms of
heparin and EDTA are entirely different their effects on the blood ammonia
determination are similar. Conversely, although the anticoagulant activities
of EDTA, sodium citrate, potassium oxalate, and sodium fluoride are
dependent on the binding of calcium, their effects on the blood ammonia
determination are entirely different.
Conway's suggestion that adenylic acid or adenosine gives rise to ammonia
in vitro is an attractive one.' These nitrogenous substances are among the
few which liberate ammonia after incubation with blood by both the Conway
and Seligson methods2'' due to the presence of the appropriate deaminases
in blood. Furthermore, heparin, in the concentration employed, is a potent
inhibitor of adenylic acid deaminase.' Although neither potassium oxalate
nor sodium fluoride are known to potentiate the activity of these enzymes,
both are potent inhibitors of glycolysis"D Either of these anticoagulants,
by interfering with the energy metabolism of the erythrocytes and acceler-
ating the breakdown of ATP' may provide sufficient substrate for the liber-
ation of ammonia by erythrocyte adenylic acid and adenosine deaminases.
Gardos, who noted similar changes in the ammonia concentration of blood in
unpublished studies, postulated a similar mechanism.'
It is also conceivable that these anticoagulants which profoundly alter
the permeability of the red cell membrane may permit the release of
ammonia-liberating substances, such as adenylic acid deaminase, in a manner
analogous to the efflux of potassium induced by sodium fluoride-"
An incidental finding of this investigation was the demonstration of
significant amounts of ammonia in blood a few seconds after withdrawal,
regardless of the anticoagulant employed. When heparin or EDTA was used
this level remained constant for periods in excess of 20 minutes. With oxa-
lated or fluoridated blood the ammonia concentration gradually increased as
a function of time. These observations, which were made on both normal
subjects and patients with hepatic disorders, contradict those of Conway
and Cooke"' who found no ammonia in oxalated blood immediately after
withdrawal. They noted a sharp rise in the blood ammonia concentration for
about three minutes after which it leveled off. Although some authors have
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confirmed Conway's findings0' others, using the same method, have been
unable to do so.""' Conway's observations have not been confirmed when
other analytic techniques have been employed."" '-'5 '- 1 The explanation
for these discordant results is not clear, although it appears that basic
differences in the analytic methods are responsible.
Conway's findings have led to the conclusion that free ammonia does
not exist normally in blood. The observations of significant amounts of
ammonia in blood immediately after withdrawal imply opposite conclusions.
Recent studies by Jacquez and Robin, and their coworkers, have demon-
strated the presence of ammonia in expired air in concentrations similar to
those measured by the Seligson-Hirahara and related methods.'9' f' It is
hoped that further investigations, which are currently in progress, may
provide better understanding of the source and significance of ammonia in
blood.
SUMMARY
The ammonia concentration of blood anticoagulated in vitro with heparin
or EDTA was identical. Progressively higher blood ammonia values were
found when sodium citrate, potassium oxalate and sodium fluoride were
used as anticoagulants. The ammonia concentration of blood measured
within a few seconds of withdrawal was the same with each of these anti-
coagulants. A progressive increase in the ammonia level of blood anti-
coagulated with potassium oxalate or sodium fluoride occurred as a function
of the time interval after shedding. No such increase took place with
heparinized or versenated blood. These anticoagulant-induced increments
were prevented by incubation at 20 C. and were accelerated at 380 C.
These phenomena may be directly related to the inhibition of glycolysis
in the erythrocytes by the fluoride or oxalate, or, indirectly, to alterations
in red cell permeability induced by these substances.
The demonstration of ammonia in blood immediately after withdrawal
supports the concept that free ammonia is present in circulating blood.
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